Libero Pharma
PrivateLast Round
VC Round
Jun 2, 2026
Total Funding Raised
$3.16M
Company Overview
Libero Pharma is a biotechnology company that develops transdermal naltrexone patch delivery systems for the management of opioid use disorder, alcohol use disorder, and other chronic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Libero Pharma Comparables
Compare Libero Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medherant Limited | 82% | |
| Alkermes plc | 62% | |
| Corium Innovations | 61% |
Libero Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 2, 2026 | ||||
| VC Round | Nov 15, 2022 | ||||
| Grant | Sep 20, 2022 | ||||
| VC Round | May 10, 2021 | ||||
| VC Round | Apr 29, 2019 |
Libero Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The TRICAPITAL Syndicate | VC Round |
| Highland Venture Capital | VC Round |
| Scottish Investment Bank (Scottish Enterprise) | VC Round |
| National Institute on Drug Abuse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2019
$320K raised from Highland Venture Capital and others.
Libero Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Libero Pharma's valuation, stock price, and market status.
Is Libero Pharma a public or private company?
Libero Pharma is a private company.
What is the current stock price of Libero Pharma?
Libero Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Libero Pharma worth (valuation)?
Valuation information for Libero Pharma is not publicly available.
Can I buy Libero Pharma stock?
Libero Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Libero Pharma's last funding round?
Libero Pharma's most recent funding round was Grant on September 20, 2022.
Who are the main investors in Libero Pharma?
Key investors in Libero Pharma include Highland Venture Capital, National Institute on Drug Abuse.
Will Libero Pharma IPO soon?
No public IPO plans have been announced for Libero Pharma.
How can I track Libero Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Libero Pharma's secondary market activity and sign up for updates.